Novel small molecule bradykinin B1 receptor antagonists. Part 2: 5-membered diaminoheterocycles.
Gunther Zischinsky, Roland Stragies, Marco Schaudt, Jochen R Pfeifer, Christoph Gibson, Elsa Locardi, Dirk Scharn, Uwe Richter, Holger Kalkhof, Klaus Dinkel, Karsten Schnatbaum
Index: Bioorg. Med. Chem. Lett. 20(3) , 1229-32, (2010)
Full Text: HTML
Abstract
Efforts to find new bradykinin B(1) receptor antagonists identified 2-aminobenzimidazole as a novel core. Subsequent transformation into five-membered diaminoheterocycle derivatives and their synthesis and SAR is described. This resulted in compounds with low nanomolar activity.Copyright (c) 2009 Elsevier Ltd. All rights reserved.
Related Compounds
Related Articles:
Aggregation of 2-aminobenzimidazole--a combined experimental and theoretical investigation.
2011-06-20
[ChemPhysChem 12(9) , 1747-55, (2011)]
Brain-penetrating 2-aminobenzimidazole H(1)-antihistamines for the treatment of insomnia.
2009-08-01
[Bioorg. Med. Chem. Lett. 19(15) , 4380-4, (2009)]
2010-03-19
[ACS Chem. Biol. 5 , 287-299, (2010)]
2009-07-01
[Bioorg. Med. Chem. Lett. 19(13) , 3568-72, (2009)]
Synthesis and QSAR studies of novel 1-substituted-2-aminobenzimidazoles derivatives.
2006-09-01
[Eur. J. Med. Chem. 41(9) , 1080-3, (2006)]